Vancomycin-variable Enterococcus faecium: In vivo emergence of vancomycin resistance in a vancomycin-susceptible isolate

Journal of Clinical Microbiology

Volumn 52, Issue 5, 2014, Pages 1766-1767

  Coburn, Bryan ^a   Low, Donald E ^a,b   Patel, Samir N ^a,c   Poutanen, Susan M ^a,b   Shahinas, Dea ^c   Eshaghi, Alireza ^c   Willey, Barbara M ^b   McGeera, Allison ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c PUBLIC HEALTH ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL PERITONITIS; CASE REPORT; CAUSE OF DEATH; ENTEROCOCCUS FAECIUM; ESOPHAGUS HEMORRHAGE; ESOPHAGUS VARICES; GENE DELETION; GENE SEQUENCE; HEPATORENAL SYNDROME; HUMAN; MALE; PRIORITY JOURNAL; SEPSIS; TRANSPOSON; TURNAROUND TIME; VANA GENE; VANR GENE; VANS GENE; DRUG EFFECTS; GENETICS; GRAM-POSITIVE BACTERIAL INFECTIONS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES;

AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; ENTEROCOCCUS FAECIUM; GENES, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84899561696     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03579-13     Document Type: Article

References (11)

1. Clinical and Laboratory Standards Institute M100-S24. 2014. Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
2. Szakacs TA, Kalan L, McConnell MJ, Eshaghi A, Shahinas D, McGeer A, Wright GD, Low DE, Patel SM. 2014. Emergence of vancomycinsusceptible Enterococcus faecium containing the wild-type vanA gene. J. Clin. Microbiol. 52:1682-1686. http://dx.doi.org/10.1128/JCM.03563-13.
3. Leclercq R, Derlot E, Duval J, Courvalin P. 1988. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319:157-161. http://dx.doi.org/10.1056/NEJM198807213190307.
4. Uttley AH, Collins CH, Naidoo J, George RC. 1988. Vancomycinresistant enterococci. Lancet. i:57-58.
5. Courvalin P. 2006. Vancomycin resistance in gram-positive cocci. Clin. Infect. Dis. 42(Suppl 1):S25-S34. http://dx.doi.org/10.1086/491711.
6. Arthur M, Reynolds PE, Depardieu F, Evers S, Dutka-Malen S, Quintiliani R, Jr, Courvalin P. 1996. Mechanisms of glycopeptide resistance in enterococci. J. Infect. 32:11-16. http://dx.doi.org/10.1016/S0163-4453 (96) 80003-X.
7. Darini AL, Palepou MF, Woodford N. 2000. Effects of the movement of insertion sequences on the structure of VanA glycopeptide resistance elements in Enterococcus faecium. Antimicrob. Agents Chemother. 44:1362-1364. http://dx.doi.org/10.1128/AAC.44.5.1362-1364.2000.
8. Alam MR, Donabedian S, Brown W, Gordon J, Chow JW, Zervos MJ, Hershberger E. 2001. Heteroresistance to vancomycin in Enterococcus faecium. J. Clin. Microbiol. 39:3379-3381. http://dx.doi.org/10.1128/JCM.39.9.3379-3381.2001.
9. Khan SA, Sung K, Layton S, Nawaz MS. 2008 Heteroresistance to vancomycin and novel point mutations in Tn1546 of Enterococcus faecium ATCC 51559. Int. J. Antimicrob. Agents. 31:27-36. http://dx.doi.org/10.1016/j.ijantimicag.2007.08. 007.
10. Gagnon S, Levesque S, Lefebvre B, Bourgault AM, Labbe AC, Roger M. 2011. vanA-containing Enterococcus faecium susceptible to vancomycin and teicoplanin because of major nucleotide deletions in Tn1546. J. Antimicrob. Chemother. 66:2758-2762. http://dx.doi.org/10.1093/jac/dkr379.
11. McGeer A, Fleming CA. 2013. Antimicrobial resistance in common hospital pathogens in Ontario: report 2012. QMP-LS News. http://www.qmpls.org/ KnowledgeCentre/Newsletter/CurrentIssue/tabid/88/entryid/303/Default.aspx.